David G. Lloyd

3.4k total citations
85 papers, 2.4k citations indexed

About

David G. Lloyd is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, David G. Lloyd has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 31 papers in Genetics and 25 papers in Organic Chemistry. Recurrent topics in David G. Lloyd's work include Estrogen and related hormone effects (25 papers), Computational Drug Discovery Methods (22 papers) and Synthesis and biological activity (11 papers). David G. Lloyd is often cited by papers focused on Estrogen and related hormone effects (25 papers), Computational Drug Discovery Methods (22 papers) and Synthesis and biological activity (11 papers). David G. Lloyd collaborates with scholars based in Ireland, United States and New Zealand. David G. Lloyd's co-authors include Mary J. Meegan, Andrew J. S. Knox, Daniela M. Zisterer, Darren Fayne, M.J. Carr, Giorgio Carta, Laura Caboni, D. Clive Williams, Lisa M. Greene and David Gubbins and has published in prestigious journals such as Nature Biotechnology, The Journal of Physical Chemistry and Biochemical Journal.

In The Last Decade

David G. Lloyd

85 papers receiving 2.3k citations

Peers

David G. Lloyd

EEBS

GENET

CTM

Honggao Yan United States

Krishna Saxena Germany

Daniel W. Fong United States

Matthias Buck United States

Fumio Yamada Japan

Achim Meyer Germany

Marguerite A. Butler United States

John N. A. Hooper Australia

Jean‐Paul Renaud France

Nicholas J. Skelton United States

Honggao Yan United States

David G. Lloyd

1.6k ×1.8

272 ×0.4

130 ×0.2

EEBS

170 ×0.3

GENET

98 ×0.2

CTM

Citations per year, relative to David G. Lloyd David G. Lloyd (= 1×) peers Honggao Yan

Countries citing papers authored by David G. Lloyd

Since Specialization

Citations

This map shows the geographic impact of David G. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Lloyd more than expected).

Fields of papers citing papers by David G. Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Lloyd. The network helps show where David G. Lloyd may publish in the future.

Co-authorship network of co-authors of David G. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Lloyd. A scholar is included among the top collaborators of David G. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Lloyd. David G. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carr, M.J., Andrew J. S. Knox, Niamh M. O’Boyle, et al.. (2019). Optimisation of estrogen receptor subtype-selectivity of a 4-Aryl-4H-chromene scaffold previously identified by virtual screening. Bioorganic & Medicinal Chemistry. 28(5). 115261–115261. 4 indexed citations

Mawhinney, Leona, Michelle E. Armstrong, Ciaran O’Reilly, et al.. (2014). Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer. Molecular Medicine. 20(1). 729–735. 53 indexed citations

Fayne, Darren, Hans W. Horn, Martin Peters, et al.. (2012). Consensus Computational Ligand‐Based Design for the Identification of Novel Modulators of Human Estrogen Receptor Alpha. Molecular Informatics. 31(3-4). 246–258. 5 indexed citations

O’Boyle, Niamh M., M.J. Carr, Lisa M. Greene, et al.. (2011). Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe. European Journal of Medicinal Chemistry. 46(9). 4595–4607. 38 indexed citations

Lloyd, David G., et al.. (2011). Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes. Current Medicinal Chemistry. 18(36). 5598–5623. 19 indexed citations

Carta, Giorgio, Martin Peters, Trevor Price, et al.. (2010). ‘tieredScreen’ – Layered Virtual Screening Tool for the Identification of Novel Estrogen Receptor Alpha Modulators. Molecular Informatics. 29(5). 421–430. 6 indexed citations

Veith, Henrike, Noel Southall, Ruili Huang, et al.. (2009). Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nature Biotechnology. 27(11). 1050–1055. 163 indexed citations

Barrett, Irene, Mary J. Meegan, M.J. Carr, et al.. (2008). Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators. Bioorganic & Medicinal Chemistry. 16(21). 9554–9573. 43 indexed citations

Meegan, Mary J., Irene Barrett, Jochen Zimmermann, et al.. (2007). Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(5). 655–666. 7 indexed citations

10.

Knox, Andrew J. S., Mary J. Meegan, & David G. Lloyd. (2006). Estrogen Receptors: Molecular Interactions, Virtual Screening and Future Prospects. Current Topics in Medicinal Chemistry. 6(3). 217–243. 23 indexed citations

11.

Carta, Giorgio, et al.. (2006). Permuting input for more effective sampling of 3D conformer space. Journal of Computer-Aided Molecular Design. 20(3). 179–190. 11 indexed citations

12.

Lloyd, David G., et al.. (2006). Oncology exploration: charting cancer medicinal chemistry space. Drug Discovery Today. 11(3-4). 149–159. 39 indexed citations

13.

Lloyd, David G., H. E. SMITH, Daniela M. Zisterer, & Mary J. Meegan. (2005). Synthesis, Structure-Activity Relationships and Antagonistic Effects in Human MCF-7 Breast Cancer Cells of Flexible Estrogen Receptor Modulators. Medicinal Chemistry. 1(4). 335–353. 15 indexed citations

14.

Meegan, Mary J. & David G. Lloyd. (2003). Advances in the Science of Estrogen Receptor Modulation. Current Medicinal Chemistry. 10(3). 181–210. 78 indexed citations

15.

Lloyd, David G.. (2000). The selection of social actions in families: II. Parental investment. Evolutionary ecology research. 2(1). 15–28. 3 indexed citations

16.

Lloyd, David G.. (2000). The selection of social actions in families: I. A collective fitness approach. Evolutionary ecology research. 2(1). 3–14. 1 indexed citations

17.

Howarth, Joshua & David G. Lloyd. (2000). Simple 1,2-aminoalcohols as strain-specific antimalarial agents. Journal of Antimicrobial Chemotherapy. 46(4). 625–628. 22 indexed citations

18.

Lloyd, David G.. (1987). Parallels between sexual strategies and other allocation strategies. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 55. 263–281. 2 indexed citations

19.

Charlesby, A. & David G. Lloyd. (1960). Radiation kinetics in anthracene-silicone mixtures. Proceedings of the Royal Society of London A Mathematical and Physical Sciences. 254(1278). 343–357. 4 indexed citations

20.

Charlesby, A. & David G. Lloyd. (1959). Competitive reactions in the irradiation of anthracene + cyclohexane solutions. Proceedings of the Royal Society of London A Mathematical and Physical Sciences. 249(1256). 51–64. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact